Document is current
Any future updates will be listed below
-
Authors
Saul, Dominik https://orcid.org/0000-0002-0673-3710
Kosinsky, Robyn Laura https://orcid.org/0000-0003-2869-7762
Atkinson, Elizabeth J.
Doolittle, Madison L.
Zhang, Xu https://orcid.org/0000-0002-9784-0481
LeBrasseur, Nathan K. https://orcid.org/0000-0002-2002-0418
Pignolo, Robert J.
Robbins, Paul D. https://orcid.org/0000-0003-1068-7099
Niedernhofer, Laura J. https://orcid.org/0000-0002-1074-1385
Ikeno, Yuji
Jurk, Diana https://orcid.org/0000-0003-4486-0857
Passos, João F. https://orcid.org/0000-0001-8765-1890
Hickson, LaTonya J.
Xue, Ailing
Monroe, David G. https://orcid.org/0000-0002-4818-0114
Tchkonia, Tamara https://orcid.org/0000-0003-4623-7145
Kirkland, James L. https://orcid.org/0000-0003-1676-4905
Farr, Joshua N. https://orcid.org/0000-0002-3179-6414
Khosla, Sundeep https://orcid.org/0000-0002-2936-4372
-
Funding
Funding for this research was provided by:
Dr. Mildred Scheel Stiftung für Krebsforschung
Foundation for the National Institutes of Health (R37 AG 013925, R33AG 61456, AG 013925, R33AG 61456, AG065868, AR070241, AG065868)
- License Information
-
More Information
Article History
Received: 23 November 2021
Accepted: 5 August 2022
First Online: 16 August 2022
Competing interests
: J.L.K., T.T., and N.K.L. have a financial interest related to this research. Patents on senolytic drugs and their uses and SASP biomarkers are held by Mayo Clinic and the University of Minnesota. This research has been reviewed by the Mayo Clinic Conflict of Interest Review Board and was conducted in compliance with Mayo Clinic Conflict of Interest policies. The remaining authors declare no competing interests
